Real-time enrollment status for this non-small cell lung cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 2:55 AM UTC
| NCT Number | NCT06875310 |
| Recruiting Status | Recruiting |
| Condition | Non-small Cell Lung Cancer |
| Phase | PHASE3 |
| Target Enrollment | 630 participants |
| Active Locations | 52 sites in the US |
| Sponsor | Mirati Therapeutics Inc. |
| Last Updated on CT.gov | August 14, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT06875310 is currently recruiting participants. This phase3 study for non-small cell lung cancer is actively seeking new participants at 52 locations across the United States. The study is sponsored by Mirati Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06875310 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 52 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06875310 was last updated 2 weeks ago (August 14, 2026). HelloStudys verifies this status automatically.